15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Roivant Sciences Ltd, 9 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $34.00 to $42.00, so the covering firms are broadly aligned. The average target of $38.60 sits 14% above the current $33.84. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 8 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.40 next quarter toward $-1.56 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Roivant Sciences Ltd.
As of Jul, 9 of 10 firms rate ROIV a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ROIV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.40
Range $-0.55 – $-0.29 · 3 analysts · +44% YoY
Next period, 3 analysts expect Roivant Sciences Ltd to earn $-0.40 a share (range $-0.55 – $-0.29), versus $-0.28 a year earlier. Full-year consensus is $-1.50, growing to $-1.56 the year after.
REVENUE · NEXT QUARTER
$4.1M
Range $0 – $13.2M · 3 analysts · +164% YoY
Revenue is expected to reach $4.1M (range $0 – $13.2M), +163.6% year-over-year. Full-year consensus is $49.3M, rising to $465.8M next year.
Top analysts covering Roivant Sciences Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ROIV.
#1
Yatin Suneja
Guggenheim · Rank #28
Buy
$36.00+6.4% to target
Overall win rate
52%
+ Follow
#2
Yasmeen Rahimi
Piper Sandler · Rank #152
Buy
$40.00+18.2% to target
Overall win rate
34%
+ Follow
#3
Douglas Tsao
HC Wainwright & Co. · Rank #212
Buy
$34.00+0.5% to target
Overall win rate
35%
+ Follow
#4
SS
Samantha Semenkow
Citigroup
Buy
$42.00+24.1% to target
Coverage
—
+ Follow
#5
Yaron Werber
TD Cowen
Buy
$41.00+21.2% to target
Coverage
—
+ Follow
ROIV stock forecast FAQ
What is ROIV's average 12-month price target?+
The 5 analysts with a live target average $38.60 for Roivant Sciences Ltd over the next 12 months, ranging from a $42.00 high to a $34.00 low.
Is ROIV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ROIV?+
The Street-high target is $42.00 (Citigroup), and the Street-low is $34.00 (HC Wainwright & Co.). The average of all 5 active targets is $38.60.
How many Wall Street analysts cover ROIV?+
10 analysts have an active rating on Roivant Sciences Ltd, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering ROIV?+
Among analysts who currently cover ROIV, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #28). Their current call is Buy with a $36.00 target.
What is Roivant Sciences Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.40 per share (range $-0.55 – $-0.29) across 3 analysts. Full-year EPS is projected at $-1.50, rising to $-1.56 the following year.
How much revenue is Roivant Sciences Ltd expected to report next quarter?+
Consensus revenue is $4.1M (range $0 – $13.2M). Full-year revenue is projected at $49.3M, growing to $465.8M next year.
Have analysts been upgrading or downgrading ROIV lately?+
As of Jul, 9 of 10 firms rate ROIV a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ROIV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
